Home/Hedge Fund Intelligence/Rhythm Pharmaceuticals, Inc.
Nasdaq: RYTMStockForm 13F30 Jun 2026

Hedge funds that hold Rhythm Pharmaceuticals, Inc. Nasdaq: RYTM

CUSIP 76243J105 · who reports it, how much, and how much it matters to them

38 of the 720 hedge fund managers we track reported shares of Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) on Form 13F for 30 June 2026. Between them they reported USD 2.5bn. The largest position belongs to Ra Capital Management, at USD 740m.

Managers reporting it38of 720 we track
Value they reportUSD 2.5bnshares only, 30 Jun 2026
Funds they run571with a file on PPLI.com
Largest positionUSD 740mRa Capital Management
Typical weight0.1%median share of a manager's book
Heaviest weight6.4%Ra Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

38 managers, USD 2.5bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Rhythm Pharmaceuticals, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Ra Capital Management1 fund on PPLI.comUSD 740m6.4%
2Baker Bros. Advisors2 funds on PPLI.comUSD 622m3.1%
3Perceptive Advisors6 funds on PPLI.comUSD 287m4.3%
4Polar Capital LLP26 funds on PPLI.comUSD 185m0.4%
5Citadel Advisors32 funds on PPLI.comUSD 140m0.0%
6Rock Springs Capital Management2 funds on PPLI.comUSD 77m3.8%
7Squarepoint Ops7 funds on PPLI.comUSD 47m0.1%
8POINT72 Asset Management17 funds on PPLI.comUSD 46m0.1%
9Sofinnova Investments1 fund on PPLI.comUSD 45m2.3%
10Adage Capital Management1 fund on PPLI.comUSD 44m0.1%
11Braidwell12 funds on PPLI.comUSD 42m1.6%
12Artisan Partners1 fund on PPLI.comUSD 39m0.1%
13Orbimed Advisors1 fund on PPLI.comUSD 36m0.7%
14Millennium Management6 funds on PPLI.comUSD 35m0.0%
15Logos Global Management1 fund on PPLI.comUSD 14m0.6%
16PFM Health Sciences3 funds on PPLI.comUSD 11m1.0%
17Sphera Funds Management1 fund on PPLI.comUSD 8.9m1.2%
18Atom Investors1 fund on PPLI.comUSD 8.2m0.7%
19Capital Fund Management S.A.12 funds on PPLI.comUSD 7.6m0.0%
20Renaissance Technologies13 funds on PPLI.comUSD 7.6m0.0%
21Exoduspoint Capital Management7 funds on PPLI.comUSD 6.8m0.0%
22Cinctive Capital Management5 funds on PPLI.comUSD 4.7m0.2%
23Zweig-Dimenna Associates3 funds on PPLI.comUSD 4.7m0.4%
24Exome Asset Management2 funds on PPLI.comUSD 3.6m2.2%
25D. E. Shaw & Co.15 funds on PPLI.comUSD 3.3m0.0%
26Schonfeld Strategic Advisors30 funds on PPLI.comUSD 3.2m0.0%
27Aquatic Capital Management3 funds on PPLI.comUSD 2.2m0.1%
28Tudor Investment Corporation10 funds on PPLI.comUSD 1.5m0.0%
29HighVista Strategies27 funds on PPLI.comUSD 1.5m0.3%
30Marshall Wace LLP84 funds on PPLI.comUSD 908,0000.0%
31Walleye Capital8 funds on PPLI.comUSD 666,0000.0%
32Fulcrum Asset Management LLP7 funds on PPLI.comUSD 556,0000.1%
33Two Sigma Investments35 funds on PPLI.comUSD 511,0000.0%
34Magnetar Financial93 funds on PPLI.comUSD 434,0000.0%
35Capstone Investment Advisors25 funds on PPLI.comUSD 334,0000.0%
36CIBC Asset Management69 funds on PPLI.comUSD 234,0000.0%
37Bayforest Capital1 fund on PPLI.comUSD 56,7360.1%
38The Quarry1 fund on PPLI.comUSD 3,2200.0%
Next: where it matters most
Where it matters most

For Ra Capital Management it is 6.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Ra Capital ManagementUSD 740m6.4%
2Perceptive AdvisorsUSD 287m4.3%
3Rock Springs Capital ManagementUSD 77m3.8%
4Baker Bros. AdvisorsUSD 622m3.1%
5Sofinnova InvestmentsUSD 45m2.3%
6Exome Asset ManagementUSD 3.6m2.2%
7BraidwellUSD 42m1.6%
8Sphera Funds ManagementUSD 8.9m1.2%
9PFM Health SciencesUSD 11m1.0%
10Atom InvestorsUSD 8.2m0.7%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Rhythm Pharmaceuticals, Inc.

What is the ticker symbol of Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. trades under the symbol RYTM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 76243J105.

Which hedge funds own Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM)?

38 of the 720 hedge fund managers PPLI.com tracks reported Rhythm Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 740m), Baker Bros. Advisors (USD 622m), Perceptive Advisors (USD 287m), Polar Capital LLP (USD 185m) and Citadel Advisors (USD 140m).

How many hedge funds hold Rhythm Pharmaceuticals, Inc.?

38 managers in our coverage reported it, and between them they run 571 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Rhythm Pharmaceuticals, Inc.?

Ra Capital Management, where the position was 6.4% of the reported 13F book at 30 June 2026.

Does this show who is short Rhythm Pharmaceuticals, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Rhythm Pharmaceuticals, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.